“Bedside-to-Bench” Behavioral Outcomes in Animal Models of Pain: Beyond the Evaluation of Reflexes

Current Neuropharmacology

Volumn 11, Issue 6, 2013, Pages 560-591

  Cobos, Enrique J ^a   Portillo Salido, Enrique ^b  

^a UNIVERSITY OF GRANADA   (Spain)

^b Drug Discovery and Preclinical Development   (Spain)

Author keywords

Analgesia; Animal model; Anxiety and depression; Behavioral outcomes; Functional disability; Pain; Sleep; Spontaneous and motivated behavior

Indexed keywords

(5 TERT BUTYL 2,3 DIHYDRO 1H INDEN 1 YL) 3 (1H INDAZOL 4 YL)UREA; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 AMINOBUTYRIC ACID A RECEPTOR; AMITRIPTYLINE; CELECOXIB; CLONIDINE; DEXAMETHASONE; DIAZEPAM; DICLOFENAC; DULOXETINE; FREUND ADJUVANT; GABAPENTIN; IBUPROFEN; INDOMETACIN; IODOACETIC ACID; KETOROLAC; LIDOCAINE; LIPOPOLYSACCHARIDE; MILNACIPRAN; MORPHINE; N (1,4 BENZODIOXAN 6 YL) 3 (4 TERT BUTYLPHENYL)ACRYLAMIDE; N (4 ISOPROPYLPHENYL) 2 (1,2,3,6 TETRAHYDRO 1,3 DIMETHYL 2,6 DIOXO 7H PURIN 7 YL)ACETAMIDE; NAPROXEN; PARACETAMOL; PREGABALIN; ROFECOXIB; TRAMADOL; UNINDEXED DRUG; VANILLOID RECEPTOR 1;

ANIMAL BEHAVIOR; ANIMAL MODEL; ARTICLE; CANCER PAIN; DISTRESS SYNDROME; ELEVATED PLUS MAZE TEST; FORCED SWIM TEST; GRIP STRENGTH; HUMAN; INFLAMMATORY PAIN; LIGHT-DARK TEST; MARBLE BURYING TEST; MECHANICAL HYPERALGESIA; NONHUMAN; NOVELTY SUPPRESSED FEEDING TEST; OPEN FIELD TEST; OSTEOARTHRITIS; PAIN ASSESSMENT; PERIPHERAL NEUROPATHY; PHENOTYPE; REM SLEEP; RODENT; SELF ADMINISTRATION TEST; SLEEP DISORDER; SOCIAL INTERACTION TEST; SUCROSE PREFERENCE TEST; TAIL SUSPENSION TEST; WALK TEST;

EID: 84899819267     PISSN: 1570159X     EISSN: 18756190     Source Type: Journal    
DOI: 10.2174/1570159X113119990041     Document Type: Article

References (260)

1. Breivik, H.; Collett, B.; Ventafridda, V.; Cohen, R.; Gallacher, D. Survey of chronic pain in Europe: prevalence, impact on daily life, and treatment. Eur. J. Pain, 2006, 10(4), 287-333.
2. Goldberg, D.S.; McGee, S.J. Pain as a global public health priority. BMC. Public Health, 2011, 11, 770.
3. Kissin, I. The development of new analgesics over the past 50 years: a lack of real breakthrough drugs. Anesth. Analg., 2010, 110(3), 780-789.
4. Mao, J.; Gold, M.S.; Backonja, M.M. Combination drug therapy for chronic pain: a call for more clinical studies. J. Pain, 2011, 12(2), 157-166.
5. Mao, J. Translational pain research: achievements and challenges. J. Pain, 2009, 10(10), 1001-1011.
6. Mao, J. Current challenges in translational pain research. Trends Pharmacol. Sci., 2012, 33(11), 568-573.
7. Mogil, J.S.; Davis, K.D.; Derbyshire, S.W. The necessity of animal models in pain research. Pain, 2010, 151(1), 12-17.
8. Mogil, J.S. Animal models of pain: progress and challenges. Nat. Rev. Neurosci., 2009, 10(4), 283-294.
9. Mogil, J.S.; Crager, S.E. What should we be measuring in behavioral studies of chronic pain in animals? Pain, 2004, 112(1-2), 12-15.
10. Blackburn-Munro, G. Pain-like behaviours in animals-how human are they? Trends Pharmacol. Sci., 2004, 25(6), 299-305.
11. Vierck, C.J.; Hansson, P.T.; Yezierski, R.P. Clinical and preclinical pain assessment: are we measuring the same thing?. Pain, 2008, 135(1-2), 7-10.
12. Barrot, M. Tests and models of nociception and pain in rodents. Neuroscience, 2012, 211, 39-50.
13. Le Bars, D.; Gozariu, M.; Cadden, S.W. Animal models of nociception. Pharmacol. Rev., 2001, 53(4), 597-652.
14. Billiau, A.; Matthys, P. Modes of action of Freund's adjuvants in experimental models of autoimmune diseases. J. Leukoc. Biol., 2001, 70(6), 849-860.
15. Watkins, L.R.; Wiertelak, E.P.; Goehler, L.E.; Smith, K.P.; Martin, D.; Maier, S.F. Characterization of cytokine-induced hyperalgesia. Brain Res., 1994, 654(1), 15-26.
16. Bon, K.; Lichtensteiger, C.A.; Wilson, S.G.; Mogil, J. Characterization of cyclophosphamide cystitis, a model of visceral and referred pain, in the mouse: species and strain differences. J. Urol., 2003, 170(3), 1008-1012.
17. D'Souza, W.N.; Ng, G.Y.; Youngblood, B.D.; Tsuji, W.; Lehto, S.G. A review of current animal models of osteoarthritis pain. Curr. Pharm. Biotechnol., 2011, 12(10), 1596-1612.
18. Wang, L.X.; Wang, Z.J. Animal and cellular models of chronic pain. Adv. Drug Deliv. Rev., 2003, 55(8), 949-965.
19. Hoke, A. Animal models of peripheral neuropathies. Neurotherapeutics., 2012, 9(2), 262-269.
20. Xiao, W.H.; Zheng, H.; Bennett, G.J. Characterization of oxaliplatin-induced chronic painful peripheral neuropathy in the rat and comparison with the neuropathy induced by paclitaxel. Neuroscience, 2012, 203, 194-206.
21. Nieto, F.R.; Cendan, C.M.; Sanchez-Fernandez, C.; Cobos, E.J.; Entrena, J.M.; Tejada, M.A.; Zamanillo, D.; Vela, J.M.; Baeyens, J.M. Role of sigma-1 receptors in paclitaxel-induced neuropathic pain in mice. J. Pain, 2012, 13(11), 1107-1121.
22. Masri, R.; Quiton, R.L.; Lucas, J.M.; Murray, P.D.; Thompson, S.M.; Keller, A. Zona incerta: a role in central pain. J. Neurophysiol., 2009, 102(1), 181-191.
23. Brennan, T.J.; Vandermeulen, E.P.; Gebhart, G.F. Characterization of a rat model of incisional pain. Pain, 1996, 64(3), 493-501.
24. Martin, T.J.; Kahn, W.R.; Eisenach, J.C. Abdominal surgery decreases food-reinforced operant responding in rats: relevance of incisional pain. Anesthesiology, 2005, 103(3), 629-637.
25. Sotocinal, S.G.; Sorge, R.E.; Zaloum, A.; Tuttle, A.H.; Martin, L.J.; Wieskopf, J.S.; Mapplebeck, J.C.; Wei, P.; Zhan, S.; Zhang, S.; McDougall, J.J.; King, O.D.; Mogil, J.S. The Rat Grimace Scale: a partially automated method for quantifying pain in the laboratory rat via facial expressions. Mol. Pain, 2011, 7, 55.
26. Buvanendran, A.; Kroin, J.S.; Kerns, J.M.; Nagalla, S.N.; Tuman, K.J. Characterization of a new animal model for evaluation of persistent postthoracotomy pain. Anesth. Analg., 2004, 99(5), 1453-1460.
27. Chaplan, S.R.; Bach, F.W.; Pogrel, J.W.; Chung, J.M.; Yaksh, T.L. Quantitative assessment of tactile allodynia in the rat paw. J. Neurosci. Methods, 1994, 53(1), 55-63.
28. Randall, L.O.; Selitto, J.J. A method for measurement of analgesic activity on inflamed tissue. Arch. Int. Pharmacodyn. Ther., 1957, 111(4), 409-419.
29. Sandkuhler, J. Models and mechanisms of hyperalgesia and allodynia. Physiol Rev., 2009, 89(2), 707-758.
30. Menéndez, L.; Lastra, A.; Meana, A.; Hidalgo, A.; Baamonde, A. Analgesic effects of loperamide in bone cancer pain in mice. Pharmacol Biochem. Behav, 2005, 81(1), 114-121.
31. Sánchez-Fernández, C.; Nieto, F.R.; Gonzalez-Cano, R.; Artacho-Cordon, A.; Romero, L.; Montilla-Garcia, A.; Zamanillo, D.; Baeyens, J.M.; Entrena, J.M.; Cobos, E.J. Potentiation of morphine-induced mechanical antinociception by sigma receptor inhibition: Role of peripheral sigma receptors. Neuropharmacology, 2013, 70, 348-358.
32. Hargreaves, K.; Dubner, R.; Brown, F.; Flores, C.; Joris, J. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain, 1988, 32(1), 77-88.
33. Choi, Y.; Yoon, Y.W.; Na, H.S.; Kim, S.H.; Chung, J.M. Behavioral signs of ongoing pain and cold allodynia in a rat model of neuropathic pain. Pain, 1994, 59(3), 369-376.
34. Morgan, D.; Carter, C.S.; DuPree, J.P.; Yezierski, R.P.; Vierck, C.J., Jr. Evaluation of prescription opioids using operant-based pain measures in rats. Exp. Clin. Psychopharmacol., 2008, 16(5), 367-375.
35. Jensen, M.P.; Chodroff, M.J.; Dworkin, R.H. The impact of neuropathic pain on health-related quality of life: review and implications. Neurology, 2007, 68(15), 1178-1182.
36. Turk, D.C.; Wack, J.T.; Kerns, R.D. An empirical examination of the "pain-behavior" construct. J. Behav. Med., 1985, 8(2), 119-130.
37. Olsson, E.; Barck, A. Correlation between clinical examination and quantitative gait analysis in patients operated upon with the Gunston-Hult knee prosthesis. Scand. J. Rehabil. Med., 1986, 18(3), 101-106.
38. Weidenhielm, L.; Svensson, O.K.; Brostrom, L.L. Surgical correction of leg alignment in unilateral knee osteoarthrosis reduces the load on the hip and knee joint bilaterally. Clin. Biomech. (Bristol., Avon.), 1995, 10(4), 217-221.
39. Keefe, F.J.; Smith, S. The assessment of pain behavior: implications for applied psychophysiology and future research directions. Appl. Psychophysiol. Biofeedback, 2002, 27(2), 117-127.
40. Kul-Panza, E.; Berker, N. Pedobarographic findings in patients with knee osteoarthritis. Am. J. Phys. Med. Rehabil., 2006, 85(3), 228-233.
41. Boyer, K.A.; Angst, M.S.; Asay, J.; Giori, N.J.; Andriacchi, T.P. Sensitivity of gait parameters to the effects of anti-inflammatory and opioid treatments in knee osteoarthritis patients. J. Orthop. Res., 2012, 30(7), 1118-1124.
42. Weigert, B.J.; Rodriquez, A.A.; Radwin, R.G.; Sherman, J. Neuromuscular and psychological characteristics in subjects with work-related forearm pain. Am. J. Phys. Med. Rehabil., 1999, 78(6), 545-551.
43. Fraser, A.; Vallow, J.; Preston, A.; Cooper, R.G. Predicting 'normal' grip strength for rheumatoid arthritis patients. Rheumatology. (Oxford), 1999, 38(6), 521-528.
44. Jones, M.E.; Bashford, G.M.; Bliokas, V.V. Weight-bearing, pain and walking velocity during primary transtibial amputee rehabilitation. Clin. Rehabil., 2001, 15(2), 172-176.
45. van Wilgen, C.P.; Akkerman, L.; Wieringa, J.; Dijkstra, P.U. Muscle strength in patients with chronic pain. Clin. Rehabil., 2003, 17(8), 885-889.
46. Onder, G.; Cesari, M.; Russo, A.; Zamboni, V.; Bernabei, R.; Landi, F. Association between daily pain and physical function among old-old adults living in the community: results from the ilSIRENTE study. Pain, 2006, 121(1-2), 53-59.
47. Bot, A.G.; Mulders, M.A.; Fostvedt, S.; Ring, D. Determinants of grip strength in healthy subjects compared to that in patients recovering from a distal radius fracture. J. Hand Surg. Am., 2012, 37(9), 1874-1880.
48. Cantarero-Villanueva, I.; Fernandez-Lao, C.; Diaz-Rodriguez, L.; Fernandez-de-Las-Penas, C.; Ruiz, J.R.; Arroyo-Morales, M. The handgrip strength test as a measure of function in breast cancer survivors: relationship to cancer-related symptoms and physical and physiologic parameters. Am. J. Phys. Med. Rehabil., 2012, 91(9), 774-782.
49. Otsuki, T.; Nakahama, H.; Niizuma, H.; Suzuki, J. Evaluation of the analgesic effects of capsaicin using a new rat model for tonic pain. Brain Res., 1986, 365(2), 235-240.
50. Tonussi, C.R.; Ferreira, S.H. Rat knee-joint carrageenin incapacitation test: an objective screen for central and peripheral analgesics. Pain, 1992, 48(3), 421-427.
51. Tetreault, P.; Dansereau, M.A.; Dore-Savard, L.; Beaudet, N.; Sarret, P. Weight bearing evaluation in inflammatory, neuropathic and cancer chronic pain in freely moving rats. Physiol Behav., 2011, 104(3), 495-502.
52. Cobos, E.J.; Ghasemlou, N.; Araldi, D.; Segal, D.; Duong, K.; Woolf, C.J. Inflammation-induced decrease in voluntary wheel running in mice: a nonreflexive test for evaluating inflammatory pain and analgesia. Pain, 2012, 153(4), 876-884.
53. Rashid, M.H.; Theberge, Y.; Elmes, S.J.; Perkins, M.N.; McIntosh, F. Pharmacological validation of early and late phase of rat mono-iodoacetate model using the Tekscan system. Eur. J. Pain, 2013, 17(2), 210-222.
54. Ghilardi, J.R.; Freeman, K.T.; Jimenez-Andrade, J.M.; Coughlin, K.A.; Kaczmarska, M.J.; Castaneda-Corral, G.; Bloom, A.P.; Kuskowski, M.A.; Mantyh, P.W. Neuroplasticity of sensory and sympathetic nerve fibers in a mouse model of a painful arthritic joint. Arthritis Rheum., 2012, 64(7), 2223-2232.
55. Schott, E.; Berge, O.G.; Angeby-Moller, K.; Hammarstrom, G.; Dalsgaard, C.J.; Brodin, E. Weight bearing as an objective measure of arthritic pain in the rat. J. Pharmacol. Toxicol. Methods, 1994, 31(2), 79-83.
56. Munro, G.; Lopez-Garcia, J.A.; Rivera-Arconada, I.; Erichsen, H.K.; Nielsen, E.O.; Larsen, J.S.; Ahring, P.K.; Mirza, N.R. Comparison of the novel subtype-selective GABAA receptor-positive allosteric modulator NS11394 [3'-[5-(1-hydroxy-1-methyl-ethyl)-benzoimidazol-1-yl]-biphenyl-2-carbonitrile] with diazepam, zolpidem, bretazenil, and gaboxadol in rat models of inflammatory and neuropathic pain. J. Pharmacol. Exp. Ther., 2008, 327(3), 969-981.
57. Huntjens, D.R.; Spalding, D.J.; Danhof, M.; Della Pasqua, O.E. Differences in the sensitivity of behavioural measures of pain to the selectivity of cyclo-oxygenase inhibitors. Eur. J. Pain, 2009, 13(5), 448-457.
58. Masocha, W.; Parvathy, S.S. Assessment of weight bearing changes and pharmacological antinociception in mice with LPS-induced monoarthritis using the Catwalk gait analysis system. Life Sci., 2009, 85(11-12), 462-469.
59. Ivanavicius, S.P.; Ball, A.D.; Heapy, C.G.; Westwood, F.R.; Murray, F.; Read, S.J. Structural pathology in a rodent model of osteoarthritis is associated with neuropathic pain: increased expression of ATF-3 and pharmacological characterisation. Pain, 2007, 128(3), 272-282.
60. Ferreira-Gomes, J.; Adaes, S.; Mendonca, M.; Castro-Lopes, J.M. Analgesic effects of lidocaine, morphine and diclofenac on movement-induced nociception, as assessed by the Knee-Bend and CatWalk tests in a rat model of osteoarthritis. Pharmacol. Biochem. Behav., 2012, 101(4), 617-624.
61. Okun, A.; Liu, P.; Davis, P.; Ren, J.; Remeniuk, B.; Brion, T.; Ossipov, M.H.; Xie, J.; Dussor, G.O.; King, T.; Porreca, F. Afferent drive elicits ongoing pain in a model of advanced osteoarthritis. Pain, 2012, 153(4), 924-933.
62. Whiteside, G.T.; Harrison, J.; Boulet, J.; Mark, L.; Pearson, M.; Gottshall, S.; Walker, K. Pharmacological characterisation of a rat model of incisional pain. Br. J. Pharmacol., 2004, 141(1), 85-91.
63. Mogil, J.S.; Graham, A.C.; Ritchie, J.; Hughes, S.F.; Austin, J.S.; Schorscher-Petcu, A.; Langford, D.J.; Bennett, G.J. Hypolocomotion, asymmetrically directed behaviors (licking, lifting, flinching, and shaking) and dynamic weight bearing (gait) changes are not measures of neuropathic pain in mice. Mol. Pain, 2010, 6, 34.
64. Nakazato-Imasato, E.; Kurebayashi, Y. Pharmacological characteristics of the hind paw weight bearing difference induced by chronic constriction injury of the sciatic nerve in rats. Life Sci., 2009, 84(17-18), 622-626.
65. Hruska, R.E.; Silbergeld, E.K. Abnormal locomotion in rats after bilateral intrastriatal injection of kainic acid. Life Sci., 1979, 25(2), 181-193.
66. Jolicoeur, F.B.; Rondeau, D.B.; Barbeau, A.; Wayner, M.J. Comparison of neurobehavioral effects induced by various experimental models of ataxia in the rat. Neurobehav. Toxicol., 1979, 1 Suppl 1, 175-178.
67. de Medinaceli, L.; Freed, W.J.; Wyatt, R.J. An index of the functional condition of rat sciatic nerve based on measurements made from walking tracks. Exp. Neurol., 1982, 77(3), 634-643.
68. Hamers, F.P.; Lankhorst, A.J.; van Laar, T.J.; Veldhuis, W.B.; Gispen, W.H. Automated quantitative gait analysis during overground locomotion in the rat: its application to spinal cord contusion and transection injuries. J. Neurotrauma, 2001, 18(2), 187-201.
69. Pallier, P.N.; Drew, C.J.; Morton, A.J. The detection and measurement of locomotor deficits in a transgenic mouse model of Huntington's disease are task-and protocol-dependent: influence of non-motor factors on locomotor function. Brain Res. Bull., 2009, 78(6), 347-355.
70. Angeby-Moller, K.; Berge, O.G.; Hamers, F.P. Using the CatWalk method to assess weight-bearing and pain behaviour in walking rats with ankle joint monoarthritis induced by carrageenan: effects of morphine and rofecoxib. J. Neurosci. Methods, 2008, 174(1), 1-9.
71. Piesla, M.J.; Leventhal, L.; Strassle, B.W.; Harrison, J.E.; Cummons, T.A.; Lu, P.; Whiteside, G.T. Abnormal gait, due to inflammation but not nerve injury, reflects enhanced nociception in preclinical pain models. Brain Res., 2009, 1295, 89-98.
72. Vrinten, D.H.; Hamers, F.F. 'CatWalk' automated quantitative gait analysis as a novel method to assess mechanical allodynia in the rat; a comparison with von Frey testing. Pain, 2003, 102(1-2), 203-209.
73. Fernihough, J.; Gentry, C.; Malcangio, M.; Fox, A.; Rediske, J.; Pellas, T.; Kidd, B.; Bevan, S.; Winter, J. Pain related behaviour in two models of osteoarthritis in the rat knee. Pain, 2004, 112(1-2), 83-93.
74. Pomonis, J.D.; Boulet, J.M.; Gottshall, S.L.; Phillips, S.; Sellers, R.; Bunton, T.; Walker, K. Development and pharmacological characterization of a rat model of osteoarthritis pain. Pain, 2005, 114(3), 339-346.
75. Brandt, K.D. Non-surgical treatment of osteoarthritis: a half century of "advances". Ann. Rheum. Dis., 2004, 63(2), 117-122.
76. Emery, P.; Koncz, T.; Pan, S.; Lowry, S. Analgesic effectiveness of celecoxib and diclofenac in patients with osteoarthritis of the hip requiring joint replacement surgery: a 12-week, multicenter, randomized, double-blind, parallel-group, double-dummy, noninferiority study. Clin. Ther., 2008, 30(1), 70-83.
77. Honore, P.; Chandran, P.; Hernandez, G.; Gauvin, D.M.; Mikusa, J.P.; Zhong, C.; Joshi, S.K.; Ghilardi, J.R.; Sevcik, M.A.; Fryer, R.M.; Segreti, J.A.; Banfor, P.N.; Marsh, K.; Neelands, T.; Bayburt, E.; Daanen, J.F.; Gomtsyan, A.; Lee, C.H.; Kort, M.E.; Reilly, R.M.; Surowy, C.S.; Kym, P.R.; Mantyh, P.W.; Sullivan, J.P.; Jarvis, M.F.; Faltynek, C.R. Repeated dosing of ABT-102, a potent and selective TRPV1 antagonist, enhances TRPV1-mediated analgesic activity in rodents, but attenuates antagonist-induced hyperthermia. Pain, 2009, 142(1-2), 27-35.
78. Hodges, P.W.; Moseley, G.L.; Gabrielsson, A.; Gandevia, S.C. Experimental muscle pain changes feedforward postural responses of the trunk muscles. Exp. Brain Res., 2003, 151(2), 262-271.
79. Hodges, P.W. Pain and motor control: From the laboratory to rehabilitation. J. Electromyogr. Kinesiol., 2011, 21(2), 220-228.
80. Kurniawan, I.T.; Seymour, B.; Vlaev, I.; Trommershauser, J.; Dolan, R.J.; Chater, N. Pain relativity in motor control. Psychol. Sci., 2010, 21(6), 840-847.
81. Ferreira-Gomes, J.; Adaes, S.; Castro-Lopes, J.M. Assessment of movement-evoked pain in osteoarthritis by the knee-bend and CatWalk tests: a clinically relevant study. J. Pain, 2008, 9(10), 945-954.
82. King, T.; Rao, S.; Vanderah, T.; Chen, Q.; Vardanyan, A.; Porreca, F. Differential blockade of nerve injury-induced shift in weight bearing and thermal and tactile hypersensitivity by milnacipran. J. Pain, 2006, 7(7), 513-520.
83. Rashid, M.H.; Theberge, Y.; Elmes, S.J.; Perkins, M.N.; McIntosh, F. Pharmacological validation of early and late phase of rat mono-iodoacetate model using the Tekscan system. Eur. J. Pain, 2012.
84. Combe, R.; Bramwell, S.; Field, M.J. The monosodium iodoacetate model of osteoarthritis: a model of chronic nociceptive pain in rats?. Neurosci. Lett., 2004, 370(2-3), 236-240.
85. Liu, P.; Okun, A.; Ren, J.; Guo, R.C.; Ossipov, M.H.; Xie, J.; King, T.; Porreca, F. Ongoing pain in the MIA model of osteoarthritis. Neurosci. Lett., 2011, 493(3), 72-75.
86. Meyer, O.A.; Tilson, H.A.; Byrd, W.C.; Riley, M.T. A method for the routine assessment of fore-and hindlimb grip strength of rats and mice. Neurobehav. Toxicol., 1979, 1(3), 233-236.
87. Tilson, H.A. Behavioral indices of neurotoxicity. Toxicol. Pathol., 1990, 18(1 Pt 2), 96-104.
88. Nevins, M.E.; Nash, S.A.; Beardsley, P.M. Quantitative grip strength assessment as a means of evaluating muscle relaxation in mice. Psychopharmacology (Berl), 1993, 110(1-2), 92-96.
89. Kehl, L.J.; Trempe, T.M.; Hargreaves, K.M. A new animal model for assessing mechanisms and management of muscle hyperalgesia. Pain, 2000, 85(3), 333-343.
90. Kehl, L.J.; Hamamoto, D.T.; Wacnik, P.W.; Croft, D.L.; Norsted, B.D.; Wilcox, G.L.; Simone, D.A. A cannabinoid agonist differentially attenuates deep tissue hyperalgesia in animal models of cancer and inflammatory muscle pain. Pain, 2003, 103(1-2), 175-186.
91. Wacnik, P.W.; Kehl, L.J.; Trempe, T.M.; Ramnaraine, M.L.; Beitz, A.J.; Wilcox, G.L. Tumor implantation in mouse humerus evokes movement-related hyperalgesia exceeding that evoked by intramuscular carrageenan. Pain, 2003, 101(1-2), 175-186.
92. Chandran, P.; Pai, M.; Blomme, E.A.; Hsieh, G.C.; Decker, M.W.; Honore, P. Pharmacological modulation of movement-evoked pain in a rat model of osteoarthritis. Eur. J. Pharmacol., 2009, 613(1-3), 39-45.
93. Lee, Y.; Pai, M.; Brederson, J.D.; Wilcox, D.; Hsieh, G.; Jarvis, M.F.; Bitner, R.S. Monosodium iodoacetate-induced joint pain is associated with increased phosphorylation of mitogen activated protein kinases in the rat spinal cord. Mol. Pain, 2011, 7, 39.
94. Watson, J.; Ring, D. Influence of psychological factors on grip strength. J. Hand Surg. Am., 2008, 33(10), 1791-1795.
95. Wright, J.G.; Young, N.L. The patient-specific index: asking patients what they want. J. Bone Joint Surg. Am., 1997, 79(7), 974-983.
96. Verhoeven, A.C.; Boers, M.; van Der, L.S. Responsiveness of the core set, response criteria, and utilities in early rheumatoid arthritis. Ann. Rheum. Dis., 2000, 59(12), 966-974.
97. Sanchez, K.; Papelard, A.; Nguyen, C.; Bendeddouche, I.; Jousse, M.; Rannou, F.; Revel, M.; Poiraudeau, S. McMaster-Toronto Arthritis Patient Preference Disability Questionnaire sensitivity to change in low back pain: influence of shifts in priorities. PLoS. One., 2011, 6(5), e20274.
98. Wright, J.G.; Santaguida, P.L.; Young, N.; Hawker, G.A.; Schemitsch, E.; Owen, J.L. Patient preferences before and after total knee arthroplasty. J. Clin. Epidemiol., 2010, 63(7), 774-782.
99. Millecamps, M.; Jourdan, D.; Leger, S.; Etienne, M.; Eschalier, A.; Ardid, D. Circadian pattern of spontaneous behavior in monarthritic rats: a novel global approach to evaluation of chronic pain and treatment effectiveness. Arthritis Rheum., 2005, 52(11), 3470-3478.
100. Larsen, J.J.; Arnt, J. Reduction in locomotor activity of arthritic rats as parameter for chronic pain: effect of morphine, acetylsalicylic acid and citalopram. Acta Pharmacol. Toxicol. (Copenh), 1985, 57(5), 345-351.
101. Urban, R.; Scherrer, G.; Goulding, E.H.; Tecott, L.H.; Basbaum, A.I. Behavioral indices of ongoing pain are largely unchanged in male mice with tissue or nerve injury-induced mechanical hypersensitivity. Pain, 2011, 152(5), 990-1000.
102. Philippe, L.; Gegout-Pottie, P.; Guingamp, C.; Bordji, K.; Terlain, B.; Netter, P.; Gillet, P. Relations between functional, inflammatory, and degenerative parameters during adjuvant arthritis in rats. Am. J. Physiol, 1997, 273(4 Pt 2), R1550-R1556.
103. Guingamp, C.; Gegout-Pottie, P.; Philippe, L.; Terlain, B.; Netter, P.; Gillet, P. Mono-iodoacetate-induced experimental osteoarthritis: a dose-response study of loss of mobility, morphology, and biochemistry. Arthritis Rheum., 1997, 40(9), 1670-1679.
104. Negus, S.S.; Vanderah, T.W.; Brandt, M.R.; Bilsky, E.J.; Becerra, L.; Borsook, D. Preclinical assessment of candidate analgesic drugs: recent advances and future challenges. J. Pharmacol. Exp. Ther., 2006, 319(2), 507-514.
105. Skinner, B.F.; Morse, W.H. Fixed-interval reinforcement of running in a wheel. J. Exp. Anal. Behav., 1958, 1(4), 371-379.
106. Montgomery, K.C.; Monkman, J.A. The relation between fear and exploratory behavior. J. Comp Physiol Psychol., 1955, 48(2), 132-136.
107. Mortola, J.P. Hamsters versus rats: ventilatory responses in adults and newborns. Respir. Physiol, 1991, 85(3), 305-317.
108. Calvino, B.; Crepon-Bernard, M.O.; Le Bars, D. Parallel clinical and behavioural studies of adjuvant-induced arthritis in the rat: possible relationship with 'chronic pain'. Behav. Brain Res., 1987, 24(1), 11-29.
109. Matson, D.J.; Broom, D.C.; Carson, S.R.; Baldassari, J.; Kehne, J.; Cortright, D.N. Inflammation-induced reduction of spontaneous activity by adjuvant: A novel model to study the effect of analgesics in rats. J. Pharmacol. Exp. Ther., 2007, 320(1), 194-201.
110. Zhu, C.Z.; Mills, C.D.; Hsieh, G.C.; Zhong, C.; Mikusa, J.; Lewis, L.G.; Gauvin, D.; Lee, C.H.; Decker, M.W.; Bannon, A.W.; Rueter, L.E.; Joshi, S.K. Assessing carrageenan-induced locomotor activity impairment in rats: comparison with evoked endpoint of acute inflammatory pain. Eur. J. Pain, 2012, 16(6), 816-826.
111. Nagase, H.; Kumakura, S.; Shimada, K. Establishment of a novel objective and quantitative method to assess pain-related behavior in monosodium iodoacetate-induced osteoarthritis in rat knee. J. Pharmacol. Toxicol. Methods, 2012, 65(1), 29-36.
112. Gregoire, S.; Michaud, V.; Chapuy, E.; Eschalier, A.; Ardid, D. Study of emotional and cognitive impairments in mononeuropathic rats: effect of duloxetine and gabapentin. Pain, 2012, 153(8), 1657-1663.
113. Mills, C.D.; Hains, B.C.; Johnson, K.M.; Hulsebosch, C.E. Strain and model differences in behavioral outcomes after spinal cord injury in rat. J. Neurotrauma, 2001, 18(8), 743-756.
114. Stevenson, G.W.; Cormier, J.; Mercer, H.; Adams, C.; Dunbar, C.; Negus, S.S.; Bilsky, E.J. Targeting pain-depressed behaviors in preclinical assays of pain and analgesia: drug effects on acetic acid-depressed locomotor activity in ICR mice. Life Sci., 2009, 85(7-8), 309-315.
115. Portillo-Salido, E.; Romero, E.; Sánchez-Arroyos, R.; Romero, L.; Zamanillo, D.; Vela, J.M. Changes in sweet preference behaviour as a primary outcome measure to evaluate pain in mice. Behav Pharmacol, 2011, 22, e-Supplement A, e57.
116. Deacon, R.M. Burrowing: a sensitive behavioural assay, tested in five species of laboratory rodents. Behav. Brain Res., 2009, 200(1), 128-133.
117. Andrews, N.; Legg, E.; Lisak, D.; Issop, Y.; Richardson, D.; Harper, S.; Huang, W.; Burgess, G.; Machin, I.; Rice, A.S. Spontaneous burrowing behaviour in the rat is reduced by peripheral nerve injury or inflammation associated pain. Eur. J. Pain, 2011.
118. Jirkof, P.; Cesarovic, N.; Rettich, A.; Nicholls, F.; Seifert, B.; Arras, M. Burrowing behavior as an indicator of post-laparotomy pain in mice. Front Behav. Neurosci., 2010, 4, 165.
119. Novak, C.M.; Burghardt, P.R.; Levine, J.A. The use of a running wheel to measure activity in rodents: relationship to energy balance, general activity, and reward. Neurosci. Biobehav. Rev., 2012, 36(3), 1001-1014.
120. Miller, L.L.; Picker, M.J.; Schmidt, K.T.; Dykstra, L.A. Effects of morphine on pain-elicited and pain-suppressed behavior in CB1 knockout and wildtype mice. Psychopharmacology (Berl), 2011, 215(3), 455-465.
121. Stevenson, G.W.; Mercer, H.; Cormier, J.; Dunbar, C.; Benoit, L.; Adams, C.; Jezierski, J.; Luginbuhl, A.; Bilsky, E.J. Monosodium iodoacetate-induced osteoarthritis produces pain-depressed wheel running in rats: implications for preclinical behavioral assessment of chronic pain. Pharmacol. Biochem. Behav., 2011, 98(1), 35-42.
122. Rice, A.S.; Cimino-Brown, D.; Eisenach, J.C.; Kontinen, V.K.; Lacroix-Fralish, M.L.; Machin, I.; Mogil, J.S.; Stohr, T. Animal models and the prediction of efficacy in clinical trials of analgesic drugs: a critical appraisal and call for uniform reporting standards. Pain, 2008, 139(2), 243-247.
123. Chesler, E.J.; Wilson, S.G.; Lariviere, W.R.; Rodriguez-Zas, S.L.; Mogil, J.S. Identification and ranking of genetic and laboratory environment factors influencing a behavioral trait, thermal nociception, via computational analysis of a large data archive. Neurosci. Biobehav. Rev., 2002, 26(8), 907-923.
124. Chesler, E.J.; Wilson, S.G.; Lariviere, W.R.; Rodriguez-Zas, S.L.; Mogil, J.S. Influences of laboratory environment on behavior. Nat. Neurosci., 2002, 5(11), 1101-1102.
125. Martin, T.J.; Zhang, Y.; Buechler, N.; Conklin, D.R.; Eisenach, J.C. Intrathecal morphine and ketorolac analgesia after surgery: comparison of spontaneous and elicited responses in rats. Pain, 2005, 113(3), 376-385.
126. Walters, E.T. Injury-related behavior and neuronal plasticity: an evolutionary perspective on sensitization, hyperalgesia, and analgesia. Int. Rev. Neurobiol., 1994, 36, 325-427.
127. Leknes, S.; Lee, M.; Berna, C.; Andersson, J.; Tracey, I. Relief as a reward: hedonic and neural responses to safety from pain. PLoS. One., 2011, 6(4), e17870.
128. Mauderli, A.P.; Acosta-Rua, A.; Vierck, C.J. An operant assay of thermal pain in conscious, unrestrained rats. J. Neurosci. Methods, 2000, 97(1), 19-29.
129. Walczak, J.S.; Beaulieu, P. Comparison of three models of neuropathic pain in mice using a new method to assess cold allodynia: the double plate technique. Neurosci. Lett., 2006, 399(3), 240-244.
130. Vierck, C.J.; Acosta-Rua, A.; Nelligan, R.; Tester, N.; Mauderli, A. Low dose systemic morphine attenuates operant escape but facilitates innate reflex responses to thermal stimulation. J. Pain, 2002, 3(4), 309-319.
131. Vierck, C.J., Jr.; Kline, R.H.; Wiley, R.G. Intrathecal substance p-saporin attenuates operant escape from nociceptive thermal stimuli. Neuroscience, 2003, 119(1), 223-232.
132. King, C.D.; Devine, D.P.; Vierck, C.J.; Mauderli, A.; Yezierski, R.P. Opioid modulation of reflex versus operant responses following stress in the rat. Neuroscience, 2007, 147(1), 174-182.
133. Vierck, C.J. Animal models of pain. In: Wall and Melzack´s Text Book of Pain 5th edition; McMahon, S., Koltzenburg, M., Eds.; Churchill Livingstone: London, 2005; pp. 175-186
134. Ercoli, N.; Lewis, M.N. Studies on analgesics; the time-action curves of morphine, codeine, dilaudid and demerol by various methods of administration; analgesic activity of acetylsalicylic acid and aminopyrine. J. Pharmacol. Exp. Ther., 1945, 84, 301-317.
135. Janicki, P.; Libich, J. Detection of antagonist activity for narcotic analgesics in mouse hot-plate test. Pharmacol. Biochem. Behav., 1979, 10(4), 623-626.
136. Rossi, H.L.; Vierck, C.J., Jr.; Caudle, R.M.; Yezierski, R.P.; Neubert, J.K. Dose-dependent effects of icilin on thermal preference in the hindpaw and face of rats. J. Pain, 2009, 10(6), 646-653.
137. Vierck, C.J.; Acosta-Rua, A.J.; Johnson, R.D. Bilateral chronic constriction of the sciatic nerve: a model of long-term cold hyperalgesia. J. Pain, 2005, 6(8), 507-517.
138. Neubert, J.K.; Widmer, C.G.; Malphurs, W.; Rossi, H.L.; Vierck, C.J., Jr.; Caudle, R.M. Use of a novel thermal operant behavioral assay for characterization of orofacial pain sensitivity. Pain, 2005, 116(3), 386-395.
139. Neubert, J.K.; Rossi, H.L.; Malphurs, W.; Vierck, C.J., Jr.; Caudle, R.M. Differentiation between capsaicin-induced allodynia and hyperalgesia using a thermal operant assay. Behav. Brain Res., 2006, 170(2), 308-315.
140. Rossi, H.L.; Vierck, C.J., Jr.; Caudle, R.M.; Neubert, J.K. Characterization of cold sensitivity and thermal preference using an operant orofacial assay. Mol. Pain, 2006, 2, 37.
141. Cunningham, C.L.; Gremel, C.M.; Groblewski, P.A. Drug-induced conditioned place preference and aversion in mice. Nat. Protoc., 2006, 1(4), 1662-1670.
142. Johansen, J.P.; Fields, H.L.; Manning, B.H. The affective component of pain in rodents: direct evidence for a contribution of the anterior cingulate cortex. Proc. Natl. Acad. Sci. U. S. A, 2001, 98(14), 8077-8082.
143. Deyama, S.; Katayama, T.; Ohno, A.; Nakagawa, T.; Kaneko, S.; Yamaguchi, T.; Yoshioka, M.; Minami, M. Activation of the beta-adrenoceptor-protein kinase A signaling pathway within the ventral bed nucleus of the stria terminalis mediates the negative affective component of pain in rats. J. Neurosci., 2008, 28(31), 7728-7736.
144. Deyama, S.; Katayama, T.; Kondoh, N.; Nakagawa, T.; Kaneko, S.; Yamaguchi, T.; Yoshioka, M.; Minami, M. Role of enhanced noradrenergic transmission within the ventral bed nucleus of the stria terminalis in visceral pain-induced aversion in rats. Behav. Brain Res., 2009, 197(2), 279-283.
145. Deyama, S.; Takishita, A.; Tanimoto, S.; Ide, S.; Nakagawa, T.; Satoh, M.; Minami, M. Roles of beta-and alpha2-adrenoceptors within the central nucleus of the amygdala in the visceral pain-induced aversion in rats. J. Pharmacol. Sci., 2010, 114(1), 123-126.
146. van der Kam, E.L.; Vry, J.D.; Schiene, K.; Tzschentke, T.M. Differential effects of morphine on the affective and the sensory component of carrageenan-induced nociception in the rat. Pain, 2008, 136(3), 373-379.
147. Rutten, K.; De Vry, J.; Robens, A.; Tzschentke, T.M.; van der Kam, E.L. Dissociation of rewarding, anti-aversive and antinociceptive effects of different classes of anti-nociceptives in the rat. Eur. J. Pain, 2011, 15(3), 299-305.
148. LaBuda, C.J.; Fuchs, P.N. A behavioral test paradigm to measure the aversive quality of inflammatory and neuropathic pain in rats. Exp. Neurol., 2000, 163(2), 490-494.
149. LaBuda, C.J.; Fuchs, P.N. Low dose aspirin attenuates escape/avoidance behavior, but does not reduce mechanical hyperalgesia in a rodent model of inflammatory pain. Neurosci. Lett., 2001, 304(3), 137-140.
150. LaGraize, S.C.; LaBuda, C.J.; Rutledge, M.A.; Jackson, R.L.; Fuchs, P.N. Differential effect of anterior cingulate cortex lesion on mechanical hypersensitivity and escape/avoidance behavior in an animal model of neuropathic pain. Exp. Neurol., 2004, 188(1), 139-148.
151. LaGraize, S.C.; Borzan, J.; Peng, Y.B.; Fuchs, P.N. Selective regulation of pain affect following activation of the opioid anterior cingulate cortex system. Exp. Neurol., 2006, 197(1), 22-30.
152. Hummel, M.; Lu, P.; Cummons, T.A.; Whiteside, G.T. The persistence of a long-term negative affective state following the induction of either acute or chronic pain. Pain, 2008, 140(3), 436-445.
153. Boyce-Rustay, J.M.; Zhong, C.; Kohnken, R.; Baker, S.J.; Simler, G.H.; Wensink, E.J.; Decker, M.W.; Honore, P. Comparison of mechanical allodynia and the affective component of inflammatory pain in rats. Neuropharmacology, 2010, 58(2), 537-543.
154. Pedersen, L.H.; Blackburn-Munro, G. Pharmacological characterisation of place escape/avoidance behaviour in the rat chronic constriction injury model of neuropathic pain. Psychopharmacology (Berl), 2006, 185(2), 208-217.
155. Brooks, J.; Tracey, I. From nociception to pain perception: imaging the spinal and supraspinal pathways. J. Anat., 2005, 207(1), 19-33.
156. Shackman, A.J.; Salomons, T.V.; Slagter, H.A.; Fox, A.S.; Winter, J.J.; Davidson, R.J. The integration of negative affect, pain and cognitive control in the cingulate cortex. Nat. Rev. Neurosci., 2011, 12(3), 154-167.
157. Sufka, K.J. Conditioned place preference paradigm: a novel approach for analgesic drug assessment against chronic pain. Pain, 1994, 58(3), 355-366.
158. Sufka, K.J.; Roach, J.T. Stimulus properties and antinociceptive effects of selective bradykinin B1 and B2 receptor antagonists in rats. Pain, 1996, 66(1), 99-103.
159. King, T.; Vera-Portocarrero, L.; Gutierrez, T.; Vanderah, T.W.; Dussor, G.; Lai, J.; Fields, H.L.; Porreca, F. Unmasking the tonic-aversive state in neuropathic pain. Nat. Neurosci., 2009, 12(11), 1364-1366.
160. Okun, A.; DeFelice, M.; Eyde, N.; Ren, J.; Mercado, R.; King, T.; Porreca, F. Transient inflammation-induced ongoing pain is driven by TRPV1 sensitive afferents. Mol. Pain, 2011, 7, 4.
161. Davoody, L.; Quiton, R.L.; Lucas, J.M.; Ji, Y.; Keller, A.; Masri, R. Conditioned place preference reveals tonic pain in an animal model of central pain. J. Pain, 2011, 12(8), 868-874.
162. Leite-Almeida, H.; Cerqueira, J.J.; Wei, H.; Ribeiro-Costa, N.; Anjos-Martins, H.; Sousa, N.; Pertovaara, A.; Almeida, A. Differential effects of left/right neuropathy on rats' anxiety and cognitive behavior. Pain, 2012, 153(11), 2218-2225.
163. Eisenach, J.C.; Rauck, R.L.; Curry, R. Intrathecal, but not intravenous adenosine reduces allodynia in patients with neuropathic pain. Pain, 2003, 105(1-2), 65-70.
164. Eisenach, J.C.; Hood, D.D.; Curry, R. Preliminary efficacy assessment of intrathecal injection of an American formulation of adenosine in humans. Anesthesiology, 2002, 96(1), 29-34.
165. LaBuda, C.J.; Fuchs, P.N. Morphine and gabapentin decrease mechanical hyperalgesia and escape/avoidance behavior in a rat model of neuropathic pain. Neurosci. Lett., 2000, 290(2), 137-140.
166. O'Connor, E.C.; Chapman, K.; Butler, P.; Mead, A.N. The predictive validity of the rat self-administration model for abuse liability. Neurosci. Biobehav. Rev., 2011, 35(3), 912-938.
167. Colpaert, F.C. Evidence that adjuvant arthritis in the rat is associated with chronic pain. Pain, 1987, 28(2), 201-222.
168. Kupers, R.; Gybels, J. The consumption of fentanyl is increased in rats with nociceptive but not with neuropathic pain. Pain, 1995, 60(2), 137-141.
169. Colpaert, F.C.; Tarayre, J.P.; Alliaga, M.; Bruins Slot, L.A.; Attal, N.; Koek, W. Opiate self-administration as a measure of chronic nociceptive pain in arthritic rats. Pain, 2001, 91(1-2), 33-45.
170. Pham, T.M.; Hagman, B.; Codita, A.; Van Loo, P.L.; Strommer, L.; Baumans, V. Housing environment influences the need for pain relief during post-operative recovery in mice. Physiol Behav., 2010, 99(5), 663-668.
171. Przewlocki, R.; Przewlocka, B. Opioids in chronic pain. Eur. J. Pharmacol., 2001, 429(1-3), 79-91.
172. Martin, T.J.; Kim, S.A.; Eisenach, J.C. Clonidine maintains intrathecal self-administration in rats following spinal nerve ligation. Pain, 2006, 125(3), 257-263.
173. Gutierrez, T.; Crystal, J.D.; Zvonok, A.M.; Makriyannis, A.; Hohmann, A.G. Self-medication of a cannabinoid CB2 agonist in an animal model of neuropathic pain. Pain, 2011, 152(9), 1976-1987.
174. Bura, A.S.; Guegan, T.; Zamanillo, D.; Vela, J.M.; Maldonado, R. Operant self-administration of a sigma ligand improves nociceptive and emotional manifestations of neuropathic pain. Eur. J. Pain, 2012.
175. Martin, T.J.; Kim, S.A.; Buechler, N.L.; Porreca, F.; Eisenach, J.C. Opioid self-administration in the nerve-injured rat: relevance of antiallodynic effects to drug consumption and effects of intrathecal analgesics. Anesthesiology, 2007, 106(2), 312-322.
176. Gatchel, R.J.; Peng, Y.B.; Peters, M.L.; Fuchs, P.N.; Turk, D.C. The biopsychosocial approach to chronic pain: scientific advances and future directions. Psychol. Bull., 2007, 133(4), 581-624.
177. Blackburn-Munro, G.; Blackburn-Munro, R.E. Chronic pain, chronic stress and depression: coincidence or consequence?. J. Neuroendocrinol., 2001, 13(12), 1009-1023.
178. Chapman, C.R.; Tuckett, R.P.; Song, C.W. Pain and stress in a systems perspective: reciprocal neural, endocrine, and immune interactions. J. Pain, 2008, 9(2), 122-145.
179. Nugent, N.R.; Tyrka, A.R.; Carpenter, L.L.; Price, L.H. Gene-environment interactions: early life stress and risk for depressive and anxiety disorders. Psychopharmacology (Berl), 2011, 214(1), 175-196.
180. Andrews, P.W.; Thomson, J.A., Jr. The bright side of being blue: depression as an adaptation for analyzing complex problems. Psychol. Rev., 2009, 116(3), 620-654.
181. El Hage, W.; Powell, J.F.; Surguladze, S.A. Vulnerability to depression: what is the role of stress genes in gene x environment interaction? Psychol. Med., 2009, 39(9), 1407-1411.
182. Gotlib, I.H.; Joormann, J.; Minor, K.L.; Hallmayer, J. HPA axis reactivity: a mechanism underlying the associations among 5-HTTLPR, stress, and depression. Biol. Psychiatry, 2008, 63(9), 847-851.
183. Taylor, S.E.; Way, B.M.; Welch, W.T.; Hilmert, C.J.; Lehman, B.J.; Eisenberger, N.I. Early family environment, current adversity, the serotonin transporter promoter polymorphism, and depressive symptomatology. Biol. Psychiatry, 2006, 60(7), 671-676.
184. Romera, I.; Montejo, A.L.; Caballero, F.; Caballero, L.; Arbesu, J.; Polavieja, P.; Desaiah, D.; Gilaberte, I. Functional impairment related to painful physical symptoms in patients with generalized anxiety disorder with or without comorbid major depressive disorder: post hoc analysis of a cross-sectional study. BMC. Psychiatry, 2011, 11, 69.
185. Batmaz, I.; Sariyildiz, M.A.; Dilek, B.; Bez, Y.; Karakoc, M.; Cevik, R. Sleep quality and associated factors in ankylosing spondylitis: relationship with disease parameters, psychological status and quality of life. Rheumatol. Int., 2012.
186. Drake, C.L.; Roehrs, T.; Roth, T. Insomnia causes, consequences, and therapeutics: an overview. Depress. Anxiety., 2003, 18(4), 163-176.
187. Pilowsky, I.; Crettenden, I.; Townley, M. Sleep disturbance in pain clinic patients. Pain, 1985, 23(1), 27-33.
188. Caldwell, J.R.; Rapoport, R.J.; Davis, J.C.; Offenberg, H.L.; Marker, H.W.; Roth, S.H.; Yuan, W.; Eliot, L.; Babul, N.; Lynch, P.M. Efficacy and safety of a once-daily morphine formulation in chronic, moderate-to-severe osteoarthritis pain: results from a randomized, placebo-controlled, double-blind trial and an open-label extension trial. J. Pain Symptom. Manage., 2002, 23(4), 278-291.
189. Wilson, K.G.; Eriksson, M.Y.; D'Eon, J.L.; Mikail, S.F.; Emery, P.C. Major depression and insomnia in chronic pain. Clin. J. Pain, 2002, 18(2), 77-83.
190. Li, Y.; Zhang, S.; Zhu, J.; Du, X.; Huang, F. Sleep disturbances are associated with increased pain, disease activity, depression, and anxiety in ankylosing spondylitis: a case-control study. Arthritis Res. Ther., 2012, 14(5), R215.
191. Ramos, A. Animal models of anxiety: do I need multiple tests?. Trends Pharmacol. Sci., 2008, 29(10), 493-498.
192. Ramos, A.; Pereira, E.; Martins, G.C.; Wehrmeister, T.D.; Izidio, G.S. Integrating the open field, elevated plus maze and light/dark box to assess different types of emotional behaviors in one single trial. Behav. Brain Res., 2008, 193(2), 277-288.
193. Njung'e, K.; Handley, S.L. Evaluation of marble-burying behavior as a model of anxiety. Pharmacol. Biochem. Behav., 1991, 38(1), 63-67.
194. Carvalho-Netto, E.F.; Nunes-de-Souza, R.L. Use of the elevated T-maze to study anxiety in mice. Behav. Brain Res., 2004, 148(1-2), 119-132.
195. Prut, L.; Belzung, C. The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review. Eur. J. Pharmacol., 2003, 463(1-3), 3-33.
196. File, S.E.; Seth, P. A review of 25 years of the social interaction test. Eur. J. Pharmacol., 2003, 463(1-3), 35-53.
197. Cryan, J.F.; Holmes, A. The ascent of mouse: advances in modelling human depression and anxiety. Nat. Rev. Drug Discov., 2005, 4(9), 775-790.
198. Portillo Salido, E.; Vela, J.M. Modelling human anxiety by animal models. In: Antidepressants, Antipsychotics, Anxiolytics: From Chemistry and Pharmacology to Clinical Application. Buschmann, H., Holenz, J., Párraga, A., Torrens, A., Vela, J., Díaz, J.L. Eds.; Wiley-VCH: Weinheim, 2007; Vol. 2, pp. 923-949.
199. Belzung, C.; Lemoine, M. Criteria of validity for animal models of psychiatric disorders: focus on anxiety disorders and depression. Biol. Mood. Anxiety. Disord., 2011, 1(1), 9.
200. Bourin, M.; Hascoet, M. The mouse light/dark box test. Eur. J. Pharmacol., 2003, 463(1-3), 55-65.
201. Nicolas, L.B.; Kolb, Y.; Prinssen, E.P. A combined marble burying-locomotor activity test in mice: a practical screening test with sensitivity to different classes of anxiolytics and antidepressants. Eur. J. Pharmacol., 2006, 547(1-3), 106-115.
202. Hasnie, F.S.; Wallace, V.C.; Hefner, K.; Holmes, A.; Rice, A.S. Mechanical and cold hypersensitivity in nerve-injured C57BL/6J mice is not associated with fear-avoidance-and depression-related behaviour. Br. J. Anaesth., 2007, 98(6), 816-822.
203. Hasnie, F.S.; Breuer, J.; Parker, S.; Wallace, V.; Blackbeard, J.; Lever, I.; Kinchington, P.R.; Dickenson, A.H.; Pheby, T.; Rice, A.S. Further characterization of a rat model of varicella zoster virus-associated pain: Relationship between mechanical hypersensitivity and anxiety-related behavior, and the influence of analgesic drugs. Neuroscience, 2007, 144(4), 1495-1508.
204. Roeska, K.; Ceci, A.; Treede, R.D.; Doods, H. Effect of high trait anxiety on mechanical hypersensitivity in male rats. Neurosci. Lett., 2009, 464(3), 160-164.
205. Matsuzawa-Yanagida, K.; Narita, M.; Nakajima, M.; Kuzumaki, N.; Niikura, K.; Nozaki, H.; Takagi, T.; Tamai, E.; Hareyama, N.; Terada, M.; Yamazaki, M.; Suzuki, T. Usefulness of antidepressants for improving the neuropathic pain-like state and pain-induced anxiety through actions at different brain sites. Neuropsychopharmacology, 2008, 33(8), 1952-1965.
206. Parent, A.J.; Beaudet, N.; Beaudry, H.; Bergeron, J.; Berube, P.; Drolet, G.; Sarret, P.; Gendron, L. Increased anxiety-like behaviors in rats experiencing chronic inflammatory pain. Behav. Brain Res., 2012, 229(1), 160-167.
207. Li, C.Q.; Zhang, J.W.; Dai, R.P.; Wang, J.; Luo, X.G.; Zhou, X.F. Surgical incision induces anxiety-like behavior and amygdala sensitization: effects of morphine and gabapentin. Pain Res. Treat., 2010, 2010, 705874.
208. Ji, G.; Fu, Y.; Ruppert, K.A.; Neugebauer, V. Pain-related anxiety-like behavior requires CRF1 receptors in the amygdala. Mol. Pain, 2007, 3, 13.
209. Shin, L.M.; Liberzon, I. The neurocircuitry of fear, stress, and anxiety disorders. Neuropsychopharmacology, 2010, 35(1), 169-191.
210. Whittle, S.L.; Colebatch, A.N.; Buchbinder, R.; Edwards, C.J.; Adams, K.; Englbrecht, M.; Hazlewood, G.; Marks, J.L.; Radner, H.; Ramiro, S.; Richards, B.L.; Tarner, I.H.; Aletaha, D.; Bombardier, C.; Landewe, R.B.; Muller-Ladner, U.; Bijlsma, J.W.; Branco, J.C.; Bykerk, V.P.; Rocha Castelar, P.G.; Catrina, A.I.; Hannonen, P.; Kiely, P.; Leeb, B.; Lie, E.; Martinez-Osuna, P.; Montecucco, C.; Ostergaard, M.; Westhovens, R.; Zochling, J.; van der, H.D. Multinational evidence-based recommendations for pain management by pharmacotherapy in inflammatory arthritis: integrating systematic literature research and expert opinion of a broad panel of rheumatologists in the 3e Initiative. Rheumatology. (Oxford), 2012, 51(8), 1416-1425.
211. Narita, M.; Kaneko, C.; Miyoshi, K.; Nagumo, Y.; Kuzumaki, N.; Nakajima, M.; Nanjo, K.; Matsuzawa, K.; Yamazaki, M.; Suzuki, T. Chronic pain induces anxiety with concomitant changes in opioidergic function in the amygdala. Neuropsychopharmacology, 2006, 31(4), 739-750.
212. Kim, H.; Chen, L.; Lim, G.; Sung, B.; Wang, S.; McCabe, M.F.; Rusanescu, G.; Yang, L.; Tian, Y.; Mao, J. Brain indoleamine 2,3-dioxygenase contributes to the comorbidity of pain and depression. J. Clin. Invest, 2012, 122(8), 2940-2954.
213. Yalcin, I.; Bohren, Y.; Waltisperger, E.; Sage-Ciocca, D.; Yin, J.C.; Freund-Mercier, M.J.; Barrot, M. A time-dependent history of mood disorders in a murine model of neuropathic pain. Biol. Psychiatry, 2011, 70(10), 946-953.
214. Goncalves, L.; Silva, R.; Pinto-Ribeiro, F.; Pego, J.M.; Bessa, J.M.; Pertovaara, A.; Sousa, N.; Almeida, A. Neuropathic pain is associated with depressive behaviour and induces neuroplasticity in the amygdala of the rat. Exp. Neurol., 2008, 213(1), 48-56.
215. Leite-Almeida, H.; Almeida-Torres, L.; Mesquita, A.R.; Pertovaara, A.; Sousa, N.; Cerqueira, J.J.; Almeida, A. The impact of age on emotional and cognitive behaviours triggered by experimental neuropathy in rats. Pain, 2009, 144(1-2), 57-65.
216. Low, L.A.; Millecamps, M.; Seminowicz, D.A.; Naso, L.; Thompson, S.J.; Stone, L.S.; Bushnell, M.C. Nerve injury causes long-term attentional deficits in rats. Neurosci. Lett., 2012, 529(2), 103-107.
217. Norman, G.J.; Karelina, K.; Zhang, N.; Walton, J.C.; Morris, J.S.; Devries, A.C. Stress and IL-1beta contribute to the development of depressive-like behavior following peripheral nerve injury. Mol. Psychiatry, 2010, 15(4), 404-414.
218. Norman, G.J.; Karelina, K.; Morris, J.S.; Zhang, N.; Cochran, M.; Courtney, D.A. Social interaction prevents the development of depressive-like behavior post nerve injury in mice: a potential role for oxytocin. Psychosom. Med., 2010, 72(6), 519-526.
219. Kontinen, V.K.; Kauppila, T.; Paananen, S.; Pertovaara, A.; Kalso, E. Behavioural measures of depression and anxiety in rats with spinal nerve ligation-induced neuropathy. Pain, 1999, 80(1-2), 341-346.
220. Suzuki, T.; Amata, M.; Sakaue, G.; Nishimura, S.; Inoue, T.; Shibata, M.; Mashimo, T. Experimental neuropathy in mice is associated with delayed behavioral changes related to anxiety and depression. Anesth. Analg., 2007, 104(6), 1570-7, table.
221. Wallace, V.C.; Blackbeard, J.; Pheby, T.; Segerdahl, A.R.; Davies, M.; Hasnie, F.; Hall, S.; McMahon, S.B.; Rice, A.S. Pharmacological, behavioural and mechanistic analysis of HIV-1 gp120 induced painful neuropathy. Pain, 2007, 133(1-3), 47-63.
222. Dai, R.P.; Li, C.Q.; Zhang, J.W.; Li, F.; Shi, X.D.; Zhang, J.Y.; Zhou, X.F. Biphasic activation of extracellular signal-regulated kinase in anterior cingulate cortex distinctly regulates the development of pain-related anxiety and mechanical hypersensitivity in rats after incision. Anesthesiology, 2011, 115(3), 604-613.
223. Zhong, X.L.; Wei, R.; Zhou, P.; Luo, Y.W.; Wang, X.Q.; Duan, J.; Bi, F.F.; Zhang, J.Y.; Li, C.Q.; Dai, R.P.; Li, F. Activation of Anterior Cingulate Cortex Extracellular Signal-Regulated Kinase-1 and-2 (ERK1/2) Regulates Acetic Acid-Induced, Pain-Related Anxiety in Adult Female Mice. Acta Histochem. Cytochem., 2012, 45(4), 219-225.
224. Porsolt, R.D.; Anton, G.; Blavet, N.; Jalfre, M. Behavioural despair in rats: a new model sensitive to antidepressant treatments. Eur. J. Pharmacol., 1978, 47(4), 379-391.
225. Steru, L.; Chermat, R.; Thierry, B.; Simon, P. The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology (Berl), 1985, 85(3), 367-370.
226. Portillo-Salido, E.; Ovalle, S.; Párraga, A.; Vela, J.M. Prospects for antidepressant drug discovery. Front. Neurosc, 2009, 3(2), 320-321.
227. Der-Avakian, A.; Markou, A. The neurobiology of anhedonia and other reward-related deficits. Trends Neurosci., 2012, 35(1), 68-77.
228. Valenstein, E.S.; Kakolewski, J.W.; Cox, V.C. Sex differences in taste preference for glucose and saccharin solutions. Science, 1967, 156(3777), 942-943.
229. Willner, P.; Muscat, R.; Papp, M. Chronic mild stress-induced anhedonia: a realistic animal model of depression. Neurosci. Biobehav. Rev., 1992, 16(4), 525-534.
230. Muscat, R.; Papp, M.; Willner, P. Reversal of stress-induced anhedonia by the atypical antidepressants, fluoxetine and maprotiline. Psychopharmacology (Berl), 1992, 109(4), 433-438.
231. Harkin, A.; Houlihan, D.D.; Kelly, J.P. Reduction in preference for saccharin by repeated unpredictable stress in mice and its prevention by imipramine. J. Psychopharmacol., 2002, 16(2), 115-123.
232. Santarelli, L.; Saxe, M.; Gross, C.; Surget, A.; Battaglia, F.; Dulawa, S.; Weisstaub, N.; Lee, J.; Duman, R.; Arancio, O.; Belzung, C.; Hen, R. Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science, 2003, 301(5634), 805-809.
233. Dharmshaktu, P.; Tayal, V.; Kalra, B.S. Efficacy of antidepressants as analgesics: a review. J. Clin. Pharmacol., 2012, 52(1), 6-17.
234. Garcia, L.S.; Comim, C.M.; Valvassori, S.S.; Reus, G.Z.; Barbosa, L.M.; Andreazza, A.C.; Stertz, L.; Fries, G.R.; Gavioli, E.C.; Kapczinski, F.; Quevedo, J. Acute administration of ketamine induces antidepressant-like effects in the forced swimming test and increases BDNF levels in the rat hippocampus. Prog. Neuropsychopharmacol. Biol. Psychiatry, 2008, 32(1), 140-144.
235. Correll, G.E.; Maleki, J.; Gracely, E.J.; Muir, J.J.; Harbut, R.E. Subanesthetic ketamine infusion therapy: a retrospective analysis of a novel therapeutic approach to complex regional pain syndrome. Pain Med., 2004, 5(3), 263-275.
236. Matsuzaki, M.; Matsushita, H.; Tomizawa, K.; Matsui, H. Oxytocin: a therapeutic target for mental disorders. J. Physiol Sci., 2012, 62(6), 441-444.
237. Wang, J.; Goffer, Y.; Xu, D.; Tukey, D.S.; Shamir, D.B.; Eberle, S.E.; Zou, A.H.; Blanck, T.J.; Ziff, E.B. A single subanesthetic dose of ketamine relieves depression-like behaviors induced by neuropathic pain in rats. Anesthesiology, 2011, 115(4), 812-821.
238. Hu, B.; Doods, H.; Treede, R.D.; Ceci, A. Depression-like behaviour in rats with mononeuropathy is reduced by the CB2-selective agonist GW405833. Pain, 2009, 143(3), 206-212.
239. Landis, C.A.; Robinson, C.R.; Levine, J.D. Sleep fragmentation in the arthritic rat. Pain, 1988, 34(1), 93-99.
240. Landis, C.A.; Levine, J.D.; Robinson, C.R. Decreased slow-wave and paradoxical sleep in a rat chronic pain model. Sleep, 1989, 12(2), 167-177.
241. Landis, C.A.; Robinson, C.R.; Helms, C.; Levine, J.D. Differential effects of acetylsalicylic acid and acetaminophen on sleep abnormalities in a rat chronic pain model. Brain Res., 1989, 488(1-2), 195-201.
242. Andersen, M.L.; Tufik, S. Altered sleep and behavioral patterns of arthritic rats. Sleep Res. Online., 2000, 3(4), 161-167.
243. Schutz, T.C.; Andersen, M.L.; Tufik, S. Sleep alterations in an experimental orofacial pain model in rats. Brain Res., 2003, 993(1-2), 164-171.
244. Schutz, T.C.; Andersen, M.L.; Tufik, S. Influence of temporomandibular joint pain on sleep patterns: role of nitric oxide. J. Dent. Res., 2004, 83(9), 693-697.
245. Schutz, T.C.; Andersen, M.L.; Tufik, S. Effects of COX-2 inhibitor in temporomandibular joint acute inflammation. J. Dent. Res., 2007, 86(5), 475-479.
246. Silva, A.; Andersen, M.L.; Tufik, S. Sleep pattern in an experimental model of osteoarthritis. Pain, 2008, 140(3), 446-455.
247. Kontinen, V.K.; Ahnaou, A.; Drinkenburg, W.H.; Meert, T.F. Sleep and EEG patterns in the chronic constriction injury model of neuropathic pain. Physiol Behav., 2003, 78(2), 241-246.
248. Andersen, M.L.; Tufik, S. Sleep patterns over 21-day period in rats with chronic constriction of sciatic nerve. Brain Res., 2003, 984(1-2), 84-92.
249. Monassi, C.R.; Bandler, R.; Keay, K.A. A subpopulation of rats show social and sleep-waking changes typical of chronic neuropathic pain following peripheral nerve injury. Eur. J. Neurosci., 2003, 17(9), 1907-1920.
250. Narita, M.; Niikura, K.; Nanjo-Niikura, K.; Narita, M.; Furuya, M.; Yamashita, A.; Saeki, M.; Matsushima, Y.; Imai, S.; Shimizu, T.; Asato, M.; Kuzumaki, N.; Okutsu, D.; Miyoshi, K.; Suzuki, M.; Tsukiyama, Y.; Konno, M.; Yomiya, K.; Matoba, M.; Suzuki, T. Sleep disturbances in a neuropathic pain-like condition in the mouse are associated with altered GABAergic transmission in the cingulate cortex. Pain, 2011, 152(6), 1358-1372.
251. Guevara-Lopez, U.; Ayala-Guerrero, F.; Covarrubias-Gomez, A.; Lopez-Munoz, F.J.; Torres-Gonzalez, R. Effect of acute gouty arthritis on sleep patterns: a preclinical study. Eur. J. Pain, 2009, 13(2), 146-153.
252. Price, D.D. Psychological and neural mechanisms of the affective dimension of pain. Science, 2000, 288(5472), 1769-1772.
253. Asiedu, M.; Ossipov, M.H.; Kaila, K.; Price, T.J. Acetazolamide and midazolam act synergistically to inhibit neuropathic pain. Pain, 2010, 148(2), 302-308.
254. Dureja, G.P.; Usmani, H.; Khan, M.; Tahseen, M.; Jamal, A. Efficacy of intrathecal midazolam with or without epidural methylprednisolone for management of post-herpetic neuralgia involving lumbosacral dermatomes. Pain Physician, 2010, 13(3), 213-221.
255. Zin, C.S.; Nissen, L.M.; Smith, M.T.; O'Callaghan, J.P.; Moore, B.J. An update on the pharmacological management of postherpetic neuralgia and painful diabetic neuropathy. CNS. Drugs, 2008, 22(5), 417-442.
256. Ito, M.; Yoshida, K.; Kimura, H.; Ozaki, N.; Kurita, K. Successful treatment of trigeminal neuralgia with milnacipran. Clin. Neuropharmacol., 2007, 30(3), 183-185.
257. Namaka, M.; Leong, C.; Grossberndt, A.; Klowak, M.; Turcotte, D.; Esfahani, F.; Gomori, A.; Intrater, H. A treatment algorithm for neuropathic pain: an update. Consult Pharm., 2009, 24(12), 885-902.
258. Whiteside, G.T.; Adedoyin, A.; Leventhal, L. Predictive validity of animal pain models? A comparison of the pharmacokinetic-pharmacodynamic relationship for pain drugs in rats and humans. Neuropharmacology, 2008, 54(5), 767-775.
259. von Hehn, C.A.; Baron, R.; Woolf, C.J. Deconstructing the neuropathic pain phenotype to reveal neural mechanisms. Neuron, 2012, 73(4), 638-652.
260. Finnerup, N.B.; Sindrup, S.H.; Jensen, T.S. The evidence for pharmacological treatment of neuropathic pain. Pain, 2010, 150(3), 573-581.